1325 Preclinical activity and safety profile of JANX007, a novel PSMA-targeting tumor-activated T Cell engager for treatment of metastatic castration-resistant prostate cancer

Authors :: Thomas DiRaimondo
Natalija Budimir
Simon Shenhav
Hua Wu
Vanessa Cicchini
Renee Jocic
Lina Ma
Fabrece Roup
Calvin Campbell
Carolina Caffaro
Hans Aerni
Ugur Eskiocak
Wayne Godfrey
Charles Winter
Marc Nasoff
Neil Gibson
David Campbell
Shahram Salek-Ardakani
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools